Science Explorer Back to mapMap
Discussion
Research facility · Gurgaon · India

Lifecare Innovations (India)

lifecareinnovations.comROR OpenAlex
Research works
1
fractional, all time
Citations
19
16.8 per fractional work
Top-10% rate
58.6%
all institutions 10.0%
Open access
26%
world 40%
International
26%
world 18%
Lifecare Innovations (India)

Not ranked overall: Lifecare Innovations (India) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Lifecare Innovations (India) work in?

In all years, 67% of research at Lifecare Innovations (India) is in Life Sciences, 33% in Health Sciences. Its largest fields are Pharmacology, Toxicology and Pharmaceutics (50%), Medicine (33%), Biochemistry, Genetics and Molecular Biology (17%).

Life Sciences: 1 fractional works · 66.7% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 50.0% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 16.7% of its workHealth Sciences: 0 fractional works · 33.3% of its workMedicine: 0 fractional works · 33.3% of its workALL ITS WORKLifecareInnovations…1fractional works, all years
Life Sciences67%Health Sciences33%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 3 fields, with their numbers
    1. Pharmacology, Toxicology and Pharmaceutics150.0%
    2. Biochemistry, Genetics and Molecular Biology016.7%
    1. Medicine033.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Lifecare Innovations (India)?

The most cited paper from Lifecare Innovations (India) is "A Review on the Stability Challenges of Advanced Biologic Therapeutics" (Sruthi Sarvepalli, Shashank Reddy Pasika, Vartika Verma et al., 2025), with 50 citations. Next come "Lipid Nanocarrier-Mediated Drug Delivery System to Enhance the Oral Bioavailability of Rifabutin" (26) and "Nanoformulations of Moxifloxacin, Econozole and Ethionamide as Novel Treatment Regimens Against MDR TB - An Experimental Study" (7).

Most cited papers
#PaperReleasedCitations
1 A Review on the Stability Challenges of Advanced Biologic Therapeutics Sruthi Sarvepalli, Shashank Reddy Pasika, Vartika Verma et al. · Pharmaceutics Open access 23 Apr 2025 50
2 Lipid Nanocarrier-Mediated Drug Delivery System to Enhance the Oral Bioavailability of Rifabutin Pradip Nirbhavane, Nalini Vemuri, Neeraj Kumar et al. · AAPS PharmSciTech 27 Jun 2016 26
3 Nanoformulations of Moxifloxacin, Econozole and Ethionamide as Novel Treatment Regimens Against MDR TB - An Experimental Study Nalini Vemuri, Gopal Krishan Khuller, Tanushree Prabhakar et al. · Current Nanoscience 3 Sep 2015 7
4 Improving access to liposomal amphotericin B worldwide Manoj Jadhav, J. Verma, Nilima Arun Kshirsagar · The Lancet Global Health Open access 18 Dec 2024 1
All 4 most cited papers, with filters and sorting

Which research topics does Lifecare Innovations (India) publish most on?

By volume in 2022-now: Viral Infectious Diseases and Gene Expression in Insects, Virus-based gene therapy research, RNA Interference and Gene Delivery and Ophthalmology and Visual Impairment Studies.

Viral Infectious Disease…0Viral Infectious Diseases and Gene Expression in Insects: 0 fractional worksVirus-based gene therapy…0Virus-based gene therapy research: 0 fractional worksRNA Interference and Gen…0RNA Interference and Gene Delivery: 0 fractional works
Molecular BiologyGenetics

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  2. 2 Virus-based gene therapy research Genetics 0 works
  3. 3 RNA Interference and Gene Delivery Molecular Biology 0 works
  4. 4 Ophthalmology and Visual Impairment Studies Epidemiology 0 works
  5. 5 Retinal Diseases and Treatments Ophthalmology 0 works
  6. 6 Retinopathy of Prematurity Studies Radiology, Nuclear Medicine and Imaging 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available25.9%not open74.1%

World: 40% of research is openly available.

with international co-authors25.9%domestic only74.1%

World: 18% is written across borders.

How has Lifecare Innovations (India)'s research output changed?

still counting20202025

Other research institutions in Gurgaon

All research institutions in Gurgaon

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Lifecare Innovations (India). Posts are plain text and can be reported.